30 June 2024, Volume 34 Issue 6
Article

Exploring the guiding role of the number of adverse pathological features in risk stratification for recurrence of stage Ⅰ-Ⅲ colorectal cancer: a retrospective cohort study of 9 875 cases

WENG Junyong, YE Zilan, ZHANG Ruoxin, LIU Qi, LI Xinxiang

2024, 34 (6): 527-536. doi: 10.19401/j.cnki.1007-3639.2024.06.001

Abstract ( 36) PDF (1213KB) ( 70 ) HTML ( 5 )

A study on mechanism of SIRT3 inducing endocrine drug resistance in breast cancer via deacetylating YME1L1

DONG Jianqiao, LI Kunyan, LI Jing, WANG Bin, WANG Yanhong, JIA Hongyan

2024, 34 (6): 537-547. doi: 10.19401/j.cnki.1007-3639.2024.06.002

Abstract ( 28) PDF (1400KB) ( 47 ) HTML ( 2 )

Integrated single-cell sequencing and transcriptome sequencing to reveal a 9-gene prognostic signature of immune cells in colorectal cancer

TANG Nan, HUANG Huixia, LIU Xiaojian

2024, 34 (6): 548-560. doi: 10.19401/j.cnki.1007-3639.2024.06.003

Abstract ( 31) PDF (1592KB) ( 54 ) HTML ( 5 )

Establishment of primary breast cancer cell line as new model for drug screening and basic research

HAO Xian, HUANG Jianjun, YANG Wenxiu, LIU Jinting, ZHANG Junhong, LUO Yubei, LI Qing, WANG Dahong, GAO Yuwei, TAN Fuyun, BO Li, ZHENG Yu, WANG Rong, FENG Jianglong, LI Jing, ZHAO Chunhua, DOU Xiaowei

2024, 34 (6): 561-570. doi: 10.19401/j.cnki.1007-3639.2024.06.004

Abstract ( 22) PDF (1357KB) ( 62 ) HTML ( 2 )

Effects of TMCO1 on proliferation and migration of cervical cancer cells

CHEN Xun, ZHENG Zhenxia, RUAN Xueru

2024, 34 (6): 571-580. doi: 10.19401/j.cnki.1007-3639.2024.06.005

Abstract ( 24) PDF (1811KB) ( 64 ) HTML ( 1 )

Contrast-enhanced computed tomography-based radiomics models for the risk categorization of thymoma

JIANG Tiaoyan, JIA Tianying, ZHANG Qin

2024, 34 (6): 581-589. doi: 10.19401/j.cnki.1007-3639.2024.06.006

Abstract ( 17) PDF (1148KB) ( 62 ) HTML ( 2 )

Review

Recent progress in the construction and application of patient-derived pancreatic cancer organoid models

CHEN Hong, CAO Zhiyun

2024, 34 (6): 590-597. doi: 10.19401/j.cnki.1007-3639.2024.06.007

Abstract ( 27) PDF (921KB) ( 70 ) HTML ( 3 )

The latest progress and prospects of 2D MXenes materials in the application of tumor diagnosis and treatment

HU Feixiang, TONG Tong, PENG Weijun

2024, 34 (6): 598-606. doi: 10.19401/j.cnki.1007-3639.2024.06.008

Abstract ( 23) PDF (961KB) ( 50 ) HTML ( 1 )

Guideline and Concensus

Expert consensus on early diagnosis and treatment of bladder cancer (2024 edition)

Urologic Chinese Oncology Group

2024, 34 (6): 607-618. doi: 10.19401/j.cnki.1007-3639.2024.06.009

Abstract ( 82) PDF (1063KB) ( 140 ) HTML ( 8 )

中国癌症杂志
    Database Indexing
  • A Guide to the Core Journals of China
  • Chinese Science Citation Database (CSCD)
  • China National Knowledge Infrastructure (CNKI)
  • Chinese Sci-tech Paper and Citation Database (CSTPCD)
  • Outsanding S&T Journals of China (2020) (F5000)
  • World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
  • SCOPUS
  • EMBASE
  • DOAJ
  • Chemical Abstracts (CA)
  • Japan Science and Technology Database (JST)
  • The Western Pacific Region Index Medicus (WPRIM)
  • EBSCO
  • Index of Copernicus International (ICI)

Competent Authorities

 The Ministry of Education of the People’s Republic of China

Sponsored by

 Fudan University Shanghai Cancer Center

Edited by

 Editorial Board of China Oncology

Editor-in-Chief

 SHAO Zhimin

Honorary Editor-in-Chief

 TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

 Shanghai Ouyang Printing Co., Ltd.

WeChat